<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1" xml:lang="zh" xsi:noNamespaceSchemaLocation="https://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1.xsd"><front><journal-meta><!-- 出版商赋予期刊ID--><journal-id journal-id-type="publisher-id">YIKE</journal-id><journal-title-group><!-- 期刊中文全称--><journal-title>安徽医科大学学报</journal-title><!-- 期刊英文全称--><journal-title xml:lang="en">Acta Universitatis Medicinalis Anhui</journal-title><!-- 期刊英文缩写--><abbrev-journal-title abbrev-type="publisher" xml:lang="en">Acta Universitatis Medicinalis Anhui</abbrev-journal-title><!-- 期刊中文缩写--><abbrev-journal-title abbrev-type="publisher">安徽医科大学学报</abbrev-journal-title></journal-title-group><!-- 期刊ISSN号--><issn pub-type="ppub">1000-1492</issn><!-- 期刊CN号--><issn pub-type="cn">34-1065/R</issn><publisher><!--出版商英文名称【预置实体】 待确认 --><publisher-name xml:lang="en">Anhui Lianzhong Printing Limited Company</publisher-name><!--出版商英文地址【预置实体】 --><publisher-loc xml:lang="en">Editorial Board of Acta Universitatis Medi-cinalis Anhui Meishan Road , Hefei 230032</publisher-loc><!-- 出版商中文名称【预置实体】--><publisher-name>《安徽医科大学学报》编辑部</publisher-name><!--出版商中文地址【预置实体】 --><publisher-loc>安徽省合肥市安徽医科大学校内老图书馆三楼</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1000–1492（2026）05–0872–08</article-id><article-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05 010</article-id><article-id pub-id-type="manuscript">V347-陈含露-糖尿病早期-</article-id><article-categories><subj-group subj-group-type="clc"><subject>R 587.2</subject><subject>R 774.7</subject></subj-group><subj-group subj-group-type="dc"><subject>A</subject></subj-group><subj-group subj-group-type="heading"><subject>基础医学研究</subject></subj-group></article-categories><title-group><article-title>糖尿病早期小鼠初级视皮层受损与功能异常情况</article-title><trans-title-group xml:lang="en"><trans-title>Early-stage diabetes induces structural damage and functional deficits in the mouse primary visual cortex</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name name-style="eastern"><surname>陈</surname><given-names>含露</given-names></name><name name-style="eastern" xml:lang="en"><surname>Chen</surname><given-names>Hanlu</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="author-notes" rid="fna1"/></contrib><contrib contrib-type="author"><name-alternatives><name name-style="eastern"><surname>汤</surname><given-names>浩琼</given-names></name><name name-style="eastern" xml:lang="en"><surname>Tang</surname><given-names>Haoqiong</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern"><surname>封</surname><given-names>利霞</given-names></name><name name-style="eastern" xml:lang="en"><surname>Feng</surname><given-names>Lixia</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/><xref ref-type="author-notes" rid="fna2"/></contrib><aff-alternatives id="aff1"><aff><institution>安徽医科大学第一附属医院眼科</institution>，<city>合肥</city>  <postal-code>230022</postal-code></aff><aff xml:lang="en"><institution>Department of Ophthalmology， The First Affiliated Hospital of Anhui Medical University</institution>， <city>Hefei</city>  <postal-code>230022</postal-code></aff></aff-alternatives></contrib-group><author-notes><corresp xml:lang="en" id="cor1"><named-content content-type="corresp-name">Feng Lixia</named-content>， E-mail： <email>lixiafeng75@fy.ahmu.edu.cn</email></corresp><fn fn-type="other" specific-use="about-author" id="fna1"><p><named-content content-type="corresp-name">陈含露</named-content>，女，硕士研究生</p></fn><fn fn-type="other" specific-use="about-author" id="fna2"><p><named-content content-type="corresp-name">封利霞</named-content>，女，教授，主任医师，博士生导师，通信作者，E-mail：<email>lixiafeng75@fy.ahmu.edu.cn</email></p></fn></author-notes><pub-date pub-type="epub" iso-8601-date="2026-04-24T10：51：31"><day>24</day><month>04</month><year>2026</year></pub-date>      <history><date date-type="received">       <day>04</day><month>03</month><year>2026</year></date>  </history><pub-date pub-type="ppub"><day>23</day><month>05</month><year>2026</year></pub-date><volume>61</volume><issue>5</issue><issue-id>16</issue-id><fpage>872</fpage><lpage>879</lpage><page-range>872-879</page-range><abstract abstract-type="key-points"><sec><title>目的</title><p>探究小鼠糖尿病早期初级视皮层（V1）形态学和神经网络功能改变。</p></sec><sec><title>方法</title><p>将32只SPF级C57BL/6J雄性小鼠随机均分为正常对照组和糖尿病组。小鼠腹腔注射链脲佐菌素（STZ）诱导建立1型糖尿病模型。造模后第4周行口服葡萄糖耐量实验（OGTT）评估模型建立情况。用尼氏染色法研究两组小鼠脑片形态学改变；通过免疫荧光实验探究两组小鼠V1区钙/钙调蛋白依赖激酶Ⅱ（CaMKⅡ）和生长抑素（SST）表达差异并用ImageJ软件分析CaMKⅡ+神经元上SST阳性信号共定位密度；采用在体细胞外电生理方法研究两组小鼠V1神经元放电特性和神经元间功能连接情况。</p></sec><sec><title>结果</title><p>尼氏染色结果显示，相比正常对照组，糖尿病组V1厚度变薄（<italic>P</italic>=0.02）、神经元密度下降（<italic>P</italic>=0.01）；免疫荧光实验结果显示，糖尿病组较正常对照组V1的SST荧光积分光密度降低（<italic>P</italic>=0.02）、平均荧光强度升高（<italic>P</italic>=0.01）、CaMKⅡ+神经元上SST阳性信号共定位密度减少；电生理研究结果显示，糖尿病组较正常对照组V1神经元动作电位波形的峰谷比、斜率绝对值均下降（<italic>P</italic>&lt;0.01），神经元间条件发放率、互信息值及格兰杰因果关系值均降低（<italic>P</italic>&lt;0.000 1）。</p></sec><sec><title>结论</title><p>糖尿病早期小鼠会出现V1萎缩，并伴SST抑制系统失调和从单神经元到神经网络的多层级功能衰退。</p></sec></abstract><trans-abstract abstract-type="key-points" xml:lang="en"><sec><title>Objective</title><p>To investigate morphological and functional neural network alterations in the primary visual cortex （V1） during early-stage diabetes.</p></sec><sec><title>Methods</title><p>32 SPF male C57BL/6J mice were randomly divided into control and diabetic groups（<italic>n</italic>=16）. Type 1 diabetes was induced by intraperitoneal injection of streptozotocin （STZ）， with model validation via oral glucose tolerance test （OGTT） at week 4. Nissl staining was used to assess morphological changes in brain slices of the two groups. Immunohistochemistry was performed to detect the expression of calcium/calmodulin-dependent protein kinase Ⅱ （CaMKⅡ） and somatostatin （SST） in the V1 area. The co-localization density of SST-positive signals on CaMKⅡ+ neurons was then quantified by ImageJ software. <italic>In vivo </italic>electrophysiology was used for studying neuronal firing and functional connectivity.</p></sec><sec><title>Results</title><p>Compared with the control mice， nissl staining showed diabetic mice exhibited significant V1 thinning （<italic>P</italic>=0.02）， reduced neuronal density （<italic>P</italic>=0.01）. Immunohistochemistry found decreased SST integral optical density （<italic>P</italic>=0.02） and elevated mean fluorescence intensity （<italic>P</italic>=0.01）， and lower SST density on CaMKⅡ+ neurons in the diabetic group than in the control group. Compared with the control mice， in vivo electrophysiology studies indicated that diabetic mice showed reduced action potential peak-to-trough ratio and the absolute values of slope （<italic>P</italic>&lt;0.01）， as well as impaired functional connectivity， including conditional firing， mutual information， and Granger causality （<italic>P</italic>&lt;0.000 1）.</p></sec><sec><title>Conclusion</title><p>Early diabetes induces V1 structural atrophy accompanied by SSTergic system disruption and multi-level functional degradation from single neurons to neural networks.</p></sec></trans-abstract><kwd-group kwd-group-type="author"><kwd>糖尿病</kwd><kwd>初级视皮层</kwd><kwd>萎缩</kwd><kwd>神经元</kwd><kwd>免疫组化</kwd><kwd>电生理</kwd></kwd-group><kwd-group xml:lang="en" kwd-group-type="author"><kwd>diabetes</kwd><kwd>primary visual cortex</kwd><kwd>atrophy</kwd><kwd>neuron</kwd><kwd>immunohistochemistry</kwd><kwd>electrophysiology</kwd></kwd-group><funding-group><award-group><funding-source>国家自然科学基金项目</funding-source><award-id>82371094</award-id></award-group><funding-statement>国家自然科学基金项目（编号：82371094）</funding-statement></funding-group><funding-group xml:lang="en"><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>82371094</award-id></award-group><funding-statement>National Natural Science Foundation of China （No. 82371094）</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="2"/><equation-count count="0"/><ref-count count="15"/><page-count count="8"/><word-count count="15556"/></counts><custom-meta-group><custom-meta><meta-name>version</meta-name><meta-value>1.0.0.25091</meta-value></custom-meta><custom-meta><meta-name>structure-time</meta-name><meta-value>2026-06-30T11:07:53</meta-value></custom-meta><custom-meta><meta-name>word-source</meta-name><meta-value>FX</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>中国糖尿病患病人数持续攀升，位居全球前列<sup>［<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R2">2</xref>］</sup>。糖尿病可导致视觉系统损伤，严重可致盲。因此，糖尿病的视觉功能损伤一直是眼科和视觉研究工作者关注的热点。研究显示在视网膜血管病变发生之前，视觉信息传递的各个节点（视网膜<sup>［<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R4">4</xref>］</sup>、外膝体、视皮层<sup>［<xref ref-type="bibr" rid="R5">5</xref>］</sup>）均可受到糖尿病的影响从而产生结构和功能的损伤。视觉中枢的损伤更早于眼部的损伤。</p><p>目前关于糖尿病视觉中枢损伤的研究多依赖影像学方法，或关注阿尔兹海默症与2型糖尿病的混合模型<sup>［<xref ref-type="bibr" rid="R6">6</xref>］</sup>，而阿尔兹海默症本身就伴有神经元丢失的表现。基于前期研究<sup>［<xref ref-type="bibr" rid="R5">5</xref>］</sup>推测糖尿病早期V1萎缩可能与特定神经元亚型损伤有关。该研究综合采用形态学、免疫组化和电生理方法，探讨糖尿病早期小鼠初级视皮层形态学改变和神经网络功能损伤情况，为探索糖尿病所致视觉损伤的神经机制奠定基础。</p><sec id="s1"><label>1</label><title>材料与方法</title><sec id="s1a"><label>1.1</label><title>材料与设备</title><sec id="s1a1"><label>1.1.1</label><title>实验动物及分组</title><p specific-use="noneIndent">7周龄的SPF级C57BL/6J雄性小鼠32只，体质量20~25 g，购自斯贝福（苏州）生物技术有限公司。将小鼠随机分配至正常对照组和糖尿病组，每组16只。所有小鼠均饲养于12 h/12 h明暗交替的SPF级环境中，温度22~25 ℃。本研究经安徽医科大学实验动物伦理委员会批准（编号：LLSC20230419）。</p></sec><sec id="s1a2"><label>1.1.2</label><title>主要试剂及仪器</title><p specific-use="noneIndent">链脲佐菌素（streptozotocin，STZ；货号S0130，美国Sigma公司）；三溴乙醇（货号T48402，美国Sigma公司）；尼氏染色液（货号C0117，上海碧云天生物技术有限公司）；钙/钙调蛋白依赖激酶Ⅱ（calcium/calmodulin-dependent protein kinase Ⅱ（CaMKⅡ）抗体（货号ab52476，英国Abcam公司）；生长抑素（somatostatin，SST）抗体（货号sc74556，美国Santa Cruz公司）。罗氏精采血糖仪及试纸（德国Roched公司）；FV3000共聚焦显微镜（日本奥林巴斯公司）；全景组织细胞定量分析系统（奥地利Tissue Gnostics公司）。1×32线性阵列电极（美国NeuroNexus公司）；细胞外电生理信号放大器（美国Blackrock microsystems公司）。</p></sec></sec><sec id="s1b"><label>1.2</label><title>方法</title><sec id="s1b1"><label>1.2.1</label><title>1型糖尿病小鼠模型建立</title><p specific-use="noneIndent">选取16只20~25 g的7周龄C57BL/6J雄性小鼠，适应喂养1周。造模前禁食6 h，测空腹血糖及体质量。次日禁食12 h，糖尿病组小鼠按40 mg/kg剂量连续5 d腹腔注射1% STZ溶液，正常对照组小鼠腹腔注射等量的枸橼酸钠缓冲液，30 min内完成注射，注射2 h后恢复喂食。STZ注射结束1周后，禁食6 h，糖尿病组小鼠测得空腹血糖≥11.1 mmol/L视为造模成功。造模后每周监测血糖，第4周行口服葡萄糖耐量试验（oral glucose tolerance test，OGTT）试验：禁食6 h后灌胃给予20%葡萄糖溶液（2 g/kg），于0、15、30、60、90、120 min测尾静脉血糖。</p></sec><sec id="s1b2"><label>1.2.2</label><title>尼氏染色</title><p specific-use="noneIndent">取STZ诱导糖尿病4周小鼠和正常对照小鼠各5只，麻醉后灌流取脑。脑组织经4%多聚甲醛固定24 h，15%、30%蔗糖溶液梯度脱水，包埋鼠脑后冷冻切片。选取对应Paxinos and Franklin's脑图谱Figure 50~51的脑片置于载玻片，4%多聚甲醛溶液固定。尼氏液覆盖脑片，于37 ℃染色10 min，蒸馏水冲洗，乙醇脱水，二甲苯透明，中性树胶封片。TG全景组织细胞定量分析系统拍摄图像（×10），分辨率96 dpi×96 dpi。根据脑图谱定位V1，用ImageJ软件基于尼氏染色阳性细胞的形态学特征（清晰可见的胞核和胞质，染色深度超过背景阈值）进行人工计数。计数由2名研究者独立完成，取平均值。神经元密度=神经元总数/计数区域面积。</p></sec><sec id="s1b3"><label>1.2.3</label><title>在体细胞外电生理记录</title><sec id="s1b3a"><label>1.2.3.1</label><title>细胞外单细胞记录法</title><p specific-use="noneIndent">采用异氟烷快速麻醉小鼠并上架固定，夹好嘴夹，持续用1% ~1.5%异氟烷和氧气混合气体麻醉小鼠。小鼠双眼涂抹红霉素眼膏防干燥。碘伏消毒头顶皮肤，剪去毛发头皮，暴露颅骨。以前囟为原点，立体定位仪调平颅顶，用小号钻头在V1区（AP：-3.5 mm，ML：±2.5 mm） 钻孔至硬脑膜并用针头挑开，暴露脑组织。用1×32线性阵列电极垂直向下插入一侧鼠脑V1皮质。小鼠面前30 cm处放置一个显示屏，分辨率为1 920 dpi×1 080 dpi，刷新率为144 Hz，与鼠体轴呈45°夹角。实验使用的视觉刺激是由Matlab软件和心理物理扩展程序包Psychtoolbox-3（PTB-3）编写的特定程序来呈现的正弦移动光栅。刺激对比度设置为高对比度95%，刺激方位为该神经元的最优方位，刺激呈现时间长度设为该神经元最优时间频率，给予的测试刺激分别为0.01、0.03、0.05、0.10、0.21、0.42、0.84 c/d的空间频率刺激。记录神经元对全视野灰色屏幕（空白刺激、亮度等于光栅平均亮度）的反应作为基线活动。每种刺激条件呈现1 s，重复10次。电生理记录在刺激开始前0.5 s启动，刺激结束后0.5 s停止。记录信号经过带通滤波（300~5 000 Hz）和噪声去除。神经元放电信号经胞外放大器放大和模数转换后，存储于计算机中以备后续离线分析。用Plexon Offline Sorter软件对采集到的神经信号进行分离，通过波形特征（峰值、面积、谷值、峰谷比和峰宽等）手动分选和识别单个unit，以分离出单个神经元的活动，再用Matlab程序进行分析。</p></sec><sec id="s1b3b"><label>1.2.3.2</label><title>初级视皮层神经元检测指标</title><p specific-use="noneIndent">① 动作电位波形参数：峰谷比（动作电位波形中峰值与谷值的电压幅度比值）、斜率（波谷后0.5 ms处波形的斜率）、波宽（波峰和波谷的时间差值）。② 诱发放电率：刺激期间放电率减去空白刺激期间放电率，取不同空间频率刺激下诱发放电率的平均值得到该神经元平均诱发放电率。③ 条件放电率（condition firing）：在一对同时记录的神经元中，将其中一个设定为参考神经元A，以其每个动作电位的发放时刻为时间对齐点，统计另一个神经元B在时间窗口内的放电次数，并将神经元B放电次数除以窗口内神经元A的放电次数得到。④ 互信息值（mutual information）： 将刺激呈现时段划分为一系列连续的时间单元，并统计每个单元内各神经元动作电位发放数目，以此将连续的电活动离散化为发放计数序列。以此构建两个神经元发放计数的经验概率分布，包括各自的边缘分布以及两者共同活动的联合分布。依据信息论的基本公式计算互信息，其值等于两个神经元各自活动的熵值之和，减去它们联合活动的熵值，计算出互信息值。⑤ 格兰杰因果关系值（Granger casuality）： 基于神经元群体在响应最优空间频率刺激时的连续活动时间序列，进行多变量格兰杰因果分析。通过比较包含和不包含一个神经元过去活动信息时对另一个神经元当前活动的预测能力，来推断信息流的方向和强度。</p></sec></sec><sec id="s1b4"><label>1.2.4</label><title>组织化学免疫荧光染色</title><p specific-use="noneIndent">取STZ诱导后第4周的糖尿病组小鼠与正常对照组小鼠各5只，麻醉并灌流取脑、固定脱水、冷冻切片。取对应Paxinos and Franklin's脑图谱Figure 49~64的脑片。10%羊血清室温封闭脑片30 min。CaMKⅡ抗体（1∶500）和SST抗体（1∶50）的一抗混合液于4 ℃孵育脑片24 h，PBS漂洗，用相应二抗混合液室温避光孵育2 h。再次漂洗，DAPI抗淬灭封片剂封片。奥林巴斯FV3000共聚焦显微镜（×20）拍摄V1图像，ImageJ分析图像，以背景区域（无CaMKⅡ胞体与SST阳性结构）随机3个矩形框（100 ~700像素）平均荧光强度的“均值+3倍标准差”为阳性信号阈值，进行共定位、平均荧光强度及积分光密度分析。</p></sec></sec><sec id="s1c"><label>1.3</label><title>统计学处理</title><p specific-use="noneIndent">采用Graphpad Prism 9.3软件进行统计学分析。计量资料用Kolmogorov-Smirnov test评估正态性，符合正态分布的计量数据以<inline-formula><alternatives><mml:math id="M1"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M001.jpg"><?fx-imagestate width="1.77800000" height="2.62466669"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M001c.jpg"><?fx-imagestate width="1.77800000" height="2.62466669"?></graphic></alternatives></inline-formula>±<italic>s</italic>表示。采用Bartlett's test证实组间方差齐性。符合正态分布且方差齐的计量数据，两组间差异采用独立样本<italic>t</italic>检验分析。符合正态分布且方差不齐的计量数据，两组间差异采用Welch's <italic>t</italic> test分析。不符合正态分布的计量数据以中位数（IQR）表示，两两比较采用Mann-Whitney test。<italic>P</italic>&lt;0.05为差异有统计学意义。</p></sec></sec><sec id="s2"><label>2</label><title>结果</title><sec id="s2a"><label>2.1</label><title>糖尿病组小鼠造模后与正常对照组小鼠的一般情况比较</title><p specific-use="noneIndent">相比正常对照组，糖尿病组小鼠在注射STZ后逐渐出现多饮、多尿、多食，并持续存在。注射STZ溶液1周后，糖尿病组16只小鼠血糖为（13.67±2.25）mmol/L。糖尿病组小鼠多蜷缩少动，对外界刺激（如声音、轻触）反应更迟缓，整体状态较正常对照小鼠萎靡，体型更小且圆润，毛发杂乱无光泽。OGTT显示糖尿病组摄入葡萄糖后血糖较正常对照组快速上升，但恢复更缓慢（<italic>t</italic>=9.21，<italic>P=</italic>0.000 8；<italic>t</italic>=13.29，<italic>P=</italic>0.000 2；<italic>t</italic>=13.25，<italic>P=</italic>0.000 2；<italic>t</italic>=11.47，<italic>P=</italic>0.000 3；<italic>t</italic>=21.75，<italic>P</italic>&lt;0.000 1；<italic>t</italic>=17.00，<italic>P</italic>&lt;0.000 1；<xref ref-type="fig" rid="F1">图1</xref>）。糖尿病组16只小鼠均造模成功。</p><fig position="float" id="F1"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.F001</object-id><label>图1</label><caption><title>两组小鼠的OGTT结果比较</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig. 1</label><title>Comparison of OGTT results between control mice and diabetes mice</title></abstract><abstract abstract-type="note"><p><sup>***</sup><italic>P</italic>&lt;0.001，<sup>****</sup><italic>P</italic>&lt;0.000 1 <italic>vs </italic>Control group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F001.eps" id="Graphic1"><?fx-imagestate width="67.73333740" height="53.26945114"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F001.jpg"><?fx-imagestate width="67.73333740" height="53.26945114"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F001c.jpg"><?fx-imagestate width="67.73333740" height="53.26945114"?></graphic></alternatives></fig></sec><sec id="s2b"><label>2.2</label><title>糖尿病早期小鼠 V1形态学变化</title><p specific-use="noneIndent">经尼氏染色后两组脑片图像，见图<xref ref-type="fig" rid="F2">2</xref>A、<xref ref-type="fig" rid="F2">2</xref>B。糖尿病组V1厚度较正常对照组明显更薄（<italic>t</italic>=2.51，<italic>P</italic>=0.02；图<xref ref-type="fig" rid="F2">2</xref>C、<xref ref-type="fig" rid="F2">2</xref>D），V1神经元密度较正常对照组显著下降（<italic>t</italic>=2.75，<italic>P</italic>=0.01；图<xref ref-type="fig" rid="F2">2</xref>E、<xref ref-type="fig" rid="F2">2</xref>F）。糖尿病组小鼠和正常对照组小鼠的半脑片面积（<italic>t</italic>=0.29，<italic>P</italic>=0.78）和外侧膝状体（lateral geniculate body，LGN）面积（<italic>t</italic>=0.98，<italic>P</italic>=0.34）的差异无统计学意义（<xref ref-type="table" rid="T1">表1</xref>）。</p><fig position="float" id="F2"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.F002</object-id><label>图2</label><caption><title>两组小鼠尼氏染色脑片图像    ×10</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig. 2</label><title>Representative Nissl-stained brain sections from the two groups of mice    ×10</title></abstract><abstract abstract-type="note"><p>A， B： Representative Nissl-stained brain sections from control and diabetes mice （scale bar： 500 μm）； C， D： Example images showing the differences in V1 thickness between control and diabetes mice； E， F： Example images illustrating the differences in neuronal density in V1 between control and diabetes mice.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F002.eps" id="Graphic2"><?fx-imagestate width="169.68609619" height="27.86944389"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F002.jpg"><?fx-imagestate width="169.68609619" height="27.86944389"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F002c.jpg"><?fx-imagestate width="169.68609619" height="27.86944389"?></graphic></alternatives></fig><table-wrap id="T1"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.T001</object-id><label>表1</label><caption><p>两组V1皮质形态学结果比较（<inline-formula><alternatives><mml:math id="M2"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M002.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M002c.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic></alternatives></inline-formula>±s）</p></caption><abstract abstract-type="caption" xml:lang="en"><label>Tab. 1</label><title>Comparison of V1 cortical morphology between the two groups （<inline-formula><alternatives><mml:math id="M3"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M002.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M002c.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic></alternatives></inline-formula>±s）</title></abstract><alternatives><table id="Table1"><thead><tr><th align="left" style="border-top:solid;border-bottom:solid;">Variable</th><th align="center" style="border-top:solid;border-bottom:solid;">Control（<italic>n</italic>=5）</th><th align="center" style="border-top:solid;border-bottom:solid;">Diabetes（<italic>n</italic>=5）</th><th align="center" style="border-top:solid;border-bottom:solid;"><italic>t </italic>value</th><th align="center" style="border-top:solid;border-bottom:solid;"><italic>P</italic> value</th></tr></thead><tbody><tr align="center"><td align="left">Thickness （μm）</td><td align="center">847.79±37.51</td><td align="center">814.07±36.05</td><td align="center">2.51</td><td align="center">0.02</td></tr><tr align="center"><td align="left">Neuronal density （cells/mm²）</td><td align="center">1 477.75±227.01</td><td align="center">1 295.40±120.35</td><td align="center">2.75</td><td align="center">0.01</td></tr><tr align="center"><td align="left">Hemispheric slice area （mm²）</td><td align="center">23.62±1.31</td><td align="center">23.74±1.02</td><td align="center">0.29</td><td align="center">0.78</td></tr><tr align="center"><td align="left" style="border-bottom:solid;">LGN area （mm²）</td><td align="center" style="border-bottom:solid;">0.34±0.07</td><td align="center" style="border-bottom:solid;">0.32±0.04</td><td align="center" style="border-bottom:solid;">0.98</td><td align="center" style="border-bottom:solid;">0.34</td></tr></tbody></table><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-T001.jpg"><?fx-imagestate width="169.79998779" height="22.96999931"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-T001c.jpg"><?fx-imagestate width="169.79998779" height="22.96999931"?></graphic></alternatives></table-wrap></sec><sec id="s2c"><label>2.3</label><title>糖尿病早期小鼠V1神经元电生理活动异常与动作电位波形变化</title><p specific-use="noneIndent">在体细胞外电生理记录实验中，两组分别记录了6只小鼠电生理数据。其中正常对照组共记录到498个神经元，糖尿病组共记录到451个神经元。正常小鼠V1神经元典型动作电位波形及参数，见<xref ref-type="fig" rid="F3">图3</xref>A。糖尿病组V1神经元动作电位曲线峰谷相对深度较正常对照组更浅，曲线更平缓，见<xref ref-type="fig" rid="F3">图3</xref>B。糖尿病组V1神经元曲线峰谷比较正常组下降（<italic>t</italic>=3.257，<italic>P</italic>=0.001 2，<xref ref-type="fig" rid="F3">图3</xref>C）。糖尿病组V1神经元曲线斜率的绝对值较正常对照组减小（<italic>t</italic>=2.797，<italic>P</italic>=0.005 3，<xref ref-type="fig" rid="F3">图3</xref>D）。两组V1神经元波宽差异无统计学意义（<italic>t</italic>=0.636 1，<italic>P</italic>=0.524 8，<xref ref-type="fig" rid="F3">图3</xref>E）。糖尿病组V1神经元诱发放电率较正常对照组升高（<italic>t</italic>=4.249，<italic>P</italic>&lt;0.000 1，<xref ref-type="fig" rid="F3">图3</xref>F）。</p><fig position="float" id="F3"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.F003</object-id><label>图3</label><caption><title>V1神经元电活动异常与动作电位波形受损</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig. 3</label><title>Impaired electrical activity and action potential waveforms in V1 neurons</title></abstract><abstract abstract-type="note"><p>A： Schematic representation of typical action potential waveform and waveform parameter in V1 neurons； B： Comparison of averaged action potential waveforms from V1 neurons between the two groups； C-F： Quantitative comparisons of action potential waveforms properties and evoked firing rates between groups； <sup>**</sup><italic>P</italic>&lt;0.01，<sup>****</sup><italic>P</italic>&lt;0.000 1 <italic>vs </italic>Control group.</p></abstract><alternatives><graphic specific-use="print" xlink:href="media/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F003.eps" id="Graphic3"><?fx-imagestate width="164.04167175" height="88.19445038"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F003.jpg"><?fx-imagestate width="164.04167175" height="88.19445038"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F003c.jpg"><?fx-imagestate width="164.04167175" height="88.19445038"?></graphic></alternatives></fig></sec><sec id="s2d"><label>2.4</label><title>糖尿病早期小鼠V1神经元网络功能连接受损</title><p specific-use="noneIndent">通过分析神经元对之间的条件放电率，绘制了反映兴奋性功能连接的热图（图4A）。正常对照组热图中存在大量密集分布的深色区域，糖尿病组热图整体色调明显更浅淡，蓝色区域稀疏且强度减弱。正常对照组典例图整体平均灰度值为186.206，糖尿病组典例图整体平均灰度值为219.871。糖尿病组V1神经元间的条件放电率0.369 2（0.348 1）、互信息值0.003 5（0.008 9）、格兰杰因果关系值0.008 6（0.010 2）均相对正常对照组的条件放电率0.441 3（0.349 5）、互信息值0.006 7（0.017 5）、格兰杰因果关系值0.011 4（0.015 6）下降，差异有统计学意义（<italic>P</italic>&lt;0.000 1，图4B-4D）。</p></sec><sec id="s2e"><label>2.5</label><title>糖尿病组小鼠V1区SST表达及抑制性输入</title><p>组织化学免疫荧光图像见<xref ref-type="fig" rid="F4">图5</xref>。由<xref ref-type="table" rid="T2">表2</xref>可知，糖尿病组V1的SST阳性信号面积荧光信号相对正常对照组V1区减少，尽管该差异未达到传统显著性水平（<italic>t</italic>=2.03，<italic>P</italic>=0.05）。采用图像阈值分析法对免疫荧光阳性信号区域进行量化，结果显示两组间V1的CaMKⅡ阳性信号面积差异无统计学意义（<italic>t</italic>=1.46，<italic>P</italic>=0.16）。糖尿病组SST荧光积分光密度相对正常对照组明显减少（<italic>t</italic>=2.68，<italic>P</italic>=0.01）。糖尿病组SST平均荧光强度显著上升（<italic>t</italic>=2.98，<italic>P</italic>=0.01）。与正常对照组相比，糖尿病组V1区CaMKⅡ+神经元上的SST阳性信号共定位密度显著降低（<italic>t</italic>=2.63，<italic>P</italic>=0.02）。两组CaMKⅡ的平均荧光强度（<italic>t</italic>=0.35，<italic>P</italic>=0.73）和荧光积分光密度（<italic>t</italic>=1.30，<italic>P</italic>=0.21）之间的差异均无统计学意义（<xref ref-type="table" rid="T2">表2</xref>）。</p><fig-group id="F4"><?fx-imagegroup-arrangement grid ="1;2;" source = "paralayout"?><label>图5</label><caption><title>正常对照组和糖尿病组V1区免疫荧光染色结果</title></caption><abstract abstract-type="caption" xml:lang="en"><label>Fig. 5</label><title>Immunohistochemistry results of V1 area in control and diabetic mice</title></abstract><abstract abstract-type="note"><p>A， F： Panoramic views of immunohistochemistry images of V1 in control （A） and diabetic （F） groups    ×20； B-E： Representative individual channel images from the partial region of V1 in control mice    ×100； G-J： Representative individual channel images from the partial region of V1 in diabetic mice    ×100.</p></abstract><fig orientation="portrait" position="float" id="F4a1"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.F4a1</object-id><caption><title>scale value for the representative control heatmap is 186.206， while that for the diabetic group is 219.871 （higher grayscale values correspond to lighter colors）； B-D： Comparisons of pairwise neuronal interactions between groups， conditional firing （B）， mutual information （C）， and Granger causality（D）； <sup>****</sup><italic>P</italic>&lt;0.000 1 <italic>vs </italic>Control group.</title></caption><alternatives><graphic specific-use="print" xlink:href="media/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a1.jpg" id="Graphic4"><?fx-imagestate width="166.17147827" height="113.81799316"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a1.jpg"><?fx-imagestate width="166.17147827" height="113.81799316"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a1c.jpg"><?fx-imagestate width="166.17147827" height="113.81799316"?></graphic></alternatives></fig><fig orientation="portrait" position="float" id="F4a2"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.F4a2</object-id><alternatives><graphic specific-use="print" xlink:href="media/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a2.eps" id="Graphic5"><?fx-imagestate width="136.87777710" height="137.58332825"?></graphic><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a2.jpg"><?fx-imagestate width="136.87777710" height="137.58332825"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-F4a2c.jpg"><?fx-imagestate width="136.87777710" height="137.58332825"?></graphic></alternatives></fig></fig-group><table-wrap id="T2"><object-id pub-id-type="doi">10.19405/j.cnki.issn1000–1492.2026.05.010.T002</object-id><label>表2</label><caption><p>两组小鼠V1区CaMK<bold>Ⅱ</bold>与SST免疫荧光及共定位定量分析结果 （<inline-formula><alternatives><mml:math id="M4"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M004.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M004c.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic></alternatives></inline-formula><italic>±s</italic>）</p></caption><abstract abstract-type="caption" xml:lang="en"><label>Tab.2</label><title>Quantitative analysis of CaMK<bold>Ⅱ</bold> and SST immunohistochemistry and their colocalization of V1 between two groups （<inline-formula><alternatives><mml:math id="M5"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M004.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-M004c.jpg"><?fx-imagestate width="1.35466671" height="2.03200006"?></graphic></alternatives></inline-formula><italic>±s</italic>）</title></abstract><alternatives><table id="Table2"><thead><tr><th align="left" style="border-top:solid;border-bottom:solid;">Variable</th><th align="center" style="border-top:solid;border-bottom:solid;">Control（<italic>n</italic>=5）</th><th align="center" style="border-top:solid;border-bottom:solid;">Diabetes（<italic>n</italic>=5）</th><th align="center" style="border-top:solid;border-bottom:solid;"><italic>t </italic>value</th><th align="center" style="border-top:solid;border-bottom:solid;"><italic>P</italic> value</th></tr></thead><tbody><tr align="center"><td align="left">CaMKⅡ-positive area （μm²）</td><td align="center">180 198.20±86 789.10</td><td align="center">142 601.48±48 835.79</td><td align="center">1.46</td><td align="center">0.16</td></tr><tr align="center"><td align="left">CaMKⅡ mean fluorescence intensity</td><td align="center">118.76±38.91</td><td align="center">125.55±63.87</td><td align="center">0.35</td><td align="center">0.73</td></tr><tr align="center"><td align="left">CaMKⅡ integrated optical density</td><td align="center">66 792.48±41 001.04</td><td align="center">49 734.17±30 201.26</td><td align="center">1.30</td><td align="center">0.21</td></tr><tr align="center"><td align="left">SST-positive area （μm²）</td><td align="center">81 629.77±62 727.35</td><td align="center">43 222.96±37 616.24</td><td align="center">2.03</td><td align="center">0.05</td></tr><tr align="center"><td align="left">SST mean fluorescence intensity</td><td align="center">57.38±10.54</td><td align="center">85.68±35.30</td><td align="center">2.98</td><td align="center">0.01</td></tr><tr align="center"><td align="left">SST integrated optical density</td><td align="center">57 742.82±48 664.86</td><td align="center">21 671.29±18 540.35</td><td align="center">2.68</td><td align="center">0.01</td></tr><tr align="center"><td align="left" style="border-bottom:solid;">Colocalization density of SST with CaMKⅡ+ neurons （counts/mm²）</td><td align="center" style="border-bottom:solid;">1 225.79±836.74</td><td align="center" style="border-bottom:solid;">599.36±385.53</td><td align="center" style="border-bottom:solid;">2.63</td><td align="center" style="border-bottom:solid;">0.02</td></tr></tbody></table><graphic specific-use="big" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-T002.jpg"><?fx-imagestate width="169.79998779" height="36.75199890"?></graphic><graphic specific-use="small" xlink:href="alternativeImage/8AC5E87A-6354-4690-87D3-20D9A6806FD0-T002c.jpg"><?fx-imagestate width="169.79998779" height="36.75199890"?></graphic></alternatives></table-wrap></sec></sec><sec id="s3"><label>3</label><title>讨论</title><p>既往研究表明，脑萎缩与神经元丢失是阿尔兹海默症<sup>［<xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R8">8</xref>］</sup>和帕金森病<sup>［<xref ref-type="bibr" rid="R9">9</xref>］</sup>等中枢神经系统退行性疾病的共同病理特征。近年来，糖尿病对中枢神经系统的损害及其与上述疾病相似的机制也受到关注<sup>［<xref ref-type="bibr" rid="R10">10</xref>］</sup>。动物实验提示，在视网膜微血管改变前，糖尿病大鼠初级视皮层锥体神经元已发生萎缩；影像学研究发现，无视网膜血管病变的2型糖尿病患者的枕叶皮层等视觉相关脑区已存在异常<sup>［<xref ref-type="bibr" rid="R11">11</xref>］</sup>。然而，目前相关研究主要依赖影像学手段，尚缺乏形态与功能层面的深入证据。本研究通过构建STZ诱导的1型糖尿病早期小鼠模型，采用尼氏染色实验观察到其V1出现厚度变薄和神经元密度降低的情况。皮层变薄是脑萎缩的典型表现<sup>［<xref ref-type="bibr" rid="R8">8</xref>］</sup>，而神经元丢失则是其病理基础，这说明糖尿病小鼠在早期已出现V1区萎缩。</p><p>本文电生理结果揭示了V1神经网络的功能障碍：糖尿病小鼠V1神经元表现为电活动异常活跃、动作电位波形变缓。更重要的是，V1神经元集群间的功能连接指标，包括条件发放率、互信息值和格兰杰因果关系值均显著下降。这些结果表明，神经元间协同放电的时序精确性、信息共享量以及信息流的方向性均受到损害，导致V1高效的信息处理网络变得松散和低效。</p><p>皮层神经元分为兴奋性神经元与抑制性神经元。兴奋性神经元（CaMKⅡ+）占皮层神经元数量的80%，主要负责神经信息的远程传递与整合，维持大脑基本生理活动<sup>［<xref ref-type="bibr" rid="R12">12</xref>］</sup>。抑制性神经元主要包括SST、PV与VIP神经元，其中SST神经元是大脑皮层中至关重要的抑制性神经元，其作用是调节兴奋性神经元活动<sup>［<xref ref-type="bibr" rid="R13">13</xref>］</sup>。本研究结果显示，糖尿病早期V1区的CaMKⅡ总体表达水平未发生显著改变，但SST的总光密度显著降低，免疫阳性面积亦呈减少趋势，而其平均荧光强度却有所上升。共定位分析显示，CaMKⅡ+神经元上的SST阳性信号密度下降。据此推测：SST荧光强度的升高可能是一种代偿反应<sup>［<xref ref-type="bibr" rid="R14">14</xref>］</sup>，即SST神经元试图通过增加神经肽表达以应对网络抑制功能减弱；共定位密度下降则从形态学上证实，SST能神经末梢对兴奋性神经元的实际支配已然减少。这种“无效代偿”最终导致网络抑制功能衰退，与电生理观测到的神经元兴奋性升高及功能连接减弱结果一致。糖尿病引发的氧化应激与持续高血糖可直接损伤神经元轴突及其末梢<sup>［<xref ref-type="bibr" rid="R15">15</xref>］</sup>；同时，糖尿病状态下脑内具有突触保护作用的脑源性神经营养因子表达减少，也可能削弱对兴奋性神经元的功能调控。因此，SST能神经末梢对兴奋性神经元支配的减弱，很可能是上述多重机制共同作用的结果。</p><p>本研究存在一定的局限性。首先，神经元共定位分析基于常规共聚焦显微成像，而非超高分辨率技术。其次，研究虽通过免疫荧光获得了目标蛋白的空间分布信息，但未经Western blot进一步验证其表达水平。此外，本研究主要关注1型糖尿病模型，其结果在2型糖尿病中的适用性尚需进一步验证。</p></sec></body><back><ref-list><title>参考文献</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Duncan</surname><given-names>B B</given-names></name>， <name name-style="eastern"><surname>Magliano</surname><given-names>D J</given-names></name>， <name name-style="eastern"><surname>Boyko</surname><given-names>E J</given-names></name></person-group>. <article-title>IDF Diabetes Atlas 11th edition 2025： global prevalence and projections for 2050</article-title>［J］. <source>Nephrol Dial Transplant</source>， <year>2025</year>， <volume>41</volume>（<issue>1</issue>）： <fpage>7</fpage>-<lpage>9</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1093/ndt/gfaf177">10.1093/ndt/gfaf177</ext-link></comment>.</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Sun</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Saeedi</surname><given-names>P</given-names></name>， <name name-style="eastern"><surname>Karuranga</surname><given-names>S</given-names></name>， <etal>et al</etal></person-group>. <article-title>IDF Diabetes Atlas： global， regional and country-level diabetes prevalence estimates for 2021 and projections for 2045</article-title>［J］. <source>Diabetes Res Clin Pract</source>， <year>2022</year>， <volume>183</volume>： <fpage>109119</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.diabres.2021.109119">10.1016/j.diabres.2021.109119</ext-link></comment>.</mixed-citation></ref><ref id="R3"><label>3</label><citation-alternatives><mixed-citation publication-type="journal" publication-format="print"><person-group><string-name>邓　里</string-name>， <string-name>李　灵</string-name>， <string-name>岳　江</string-name>， <etal>等</etal></person-group>. <article-title>糖尿病视网膜病变中Gas6/MerTK/GPX4信号通路参与铁诱导的细胞死亡的作用研究</article-title>［J］. <source>安徽医科大学学报</source>， <year>2024</year>， <volume>59</volume>（<issue>10</issue>）： <fpage>1777</fpage>-<lpage>84</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.19405/j.cnki.issn1000-1492.2024.10.012">10.19405/j.cnki.issn1000-1492.2024.10.012</ext-link></comment>.</mixed-citation><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Deng</surname><given-names>L</given-names></name>， <name name-style="eastern"><surname>Li</surname><given-names>L</given-names></name>， <name name-style="eastern"><surname>Yue</surname><given-names>J</given-names></name>， <etal>et al</etal></person-group>. <article-title>The role of Gas6/MerTK/GPX4 signal pathway in iron-induced cell death in diabetic retinopathy</article-title>［J］. <source>Acta Univ Med Anhui</source>， <year>2024</year>， <volume>59</volume>（<issue>10</issue>）： <fpage>1777</fpage>-<lpage>84</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.19405/j.cnki.issn1000-1492.2024.10.012">10.19405/j.cnki.issn1000-1492.2024.10.012</ext-link></comment>.</mixed-citation></citation-alternatives></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Marchesi</surname><given-names>N</given-names></name>， <name name-style="eastern"><surname>Fahmideh</surname><given-names>F</given-names></name>， <name name-style="eastern"><surname>Boschi</surname><given-names>F</given-names></name>， <etal>et al</etal></person-group>. <article-title>Ocular neurodegenerative diseases： interconnection between retina and cortical areas</article-title>［J］. <source>Cells</source>， <year>2021</year>， <volume>10</volume>（<issue>9</issue>）： <fpage>2394</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3390/cells10092394">10.3390/cells10092394</ext-link></comment>.</mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Chen</surname><given-names>H</given-names></name>， <name name-style="eastern"><surname>Wang</surname><given-names>M</given-names></name>， <name name-style="eastern"><surname>Xia</surname><given-names>L</given-names></name>， <etal>et al</etal></person-group>. <article-title>New evidence of central nervous system damage in diabetes： impairment of fine visual discrimination</article-title>［J］. <source>Diabetes</source>， <year>2022</year>， <volume>71</volume>（<issue>8</issue>）： <fpage>1772</fpage>-<lpage>84</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.2337/db21-0715">10.2337/db21-0715</ext-link></comment>.</mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Carranza-Naval</surname><given-names>M J</given-names></name>， <name name-style="eastern"><surname>del Marco</surname><given-names>A</given-names></name>， <name name-style="eastern"><surname>Hierro-Bujalance</surname><given-names>C</given-names></name>， <etal>et al</etal></person-group>. <article-title>Liraglutide reduces vascular damage， neuronal loss， and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes</article-title>［J］. <source>Front Aging Neurosci</source>， <year>2021</year>， <volume>13</volume>： <fpage>741923</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3389/fnagi.2021.741923">10.3389/fnagi.2021.741923</ext-link></comment>.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Cedres</surname><given-names>N</given-names></name>， <name name-style="eastern"><surname>Ekman</surname><given-names>U</given-names></name>， <name name-style="eastern"><surname>Poulakis</surname><given-names>K</given-names></name>， <etal>et al</etal></person-group>. <article-title>Brain atrophy subtypes and the ATN classification scheme in Alzheimer’s disease</article-title>［J］. <source>Neurodegener Dis</source>， <year>2021</year>， <volume>20</volume>（<issue>4</issue>）： <fpage>153</fpage>-<lpage>64</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1159/000515322">10.1159/000515322</ext-link></comment>.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Jeong</surname><given-names>W C</given-names></name>， <name name-style="eastern"><surname>Min</surname><given-names>J Y</given-names></name>， <name name-style="eastern"><surname>Kang</surname><given-names>T G</given-names></name>， <etal>et al</etal></person-group>. <article-title>Association between pseudoexfoliation and Alzheimer’s disease-related brain atrophy</article-title>［J］. <source>PLoS One</source>， <year>2023</year>， <volume>18</volume>（<issue>6</issue>）： <elocation-id>e0286727</elocation-id>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pone.0286727">10.1371/journal.pone.0286727</ext-link></comment>.</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Aludin</surname><given-names>S</given-names></name>， <name name-style="eastern"><surname>Schmill</surname><given-names>L A</given-names></name></person-group>. <article-title>MRI signs of Parkinson’s disease and atypical Parkinsonism</article-title>［J］. <source>Rofo</source>， <year>2021</year>， <volume>193</volume>（<issue>12</issue>）： <fpage>1403</fpage>-<lpage>10</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1055/a-1460-8795">10.1055/a-1460-8795</ext-link></comment>.</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Ebrahimi</surname><given-names>M</given-names></name>， <name name-style="eastern"><surname>Thompson</surname><given-names>P</given-names></name>， <name name-style="eastern"><surname>Lauer</surname><given-names>A K</given-names></name>， <etal>et al</etal></person-group>. <article-title>The retina-brain axis and diabetic retinopathy</article-title>［J］. <source>Eur J Ophthalmol</source>， <year>2023</year>， <volume>33</volume>（<issue>6</issue>）： <fpage>2079</fpage>-<lpage>95</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1177/11206721231172229">10.1177/11206721231172229</ext-link></comment>.</mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Zhang</surname><given-names>D</given-names></name>， <name name-style="eastern"><surname>Huang</surname><given-names>Y</given-names></name>， <name name-style="eastern"><surname>Gao</surname><given-names>J</given-names></name>， <etal>et al</etal></person-group>. <article-title>Altered functional topological organization in type-2 diabetes mellitus with and without microvascular complications</article-title>［J］. <source>Front Neurosci</source>， <year>2021</year>， <volume>15</volume>： <fpage>726350</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.3389/fnins.2021.726350">10.3389/fnins.2021.726350</ext-link></comment>.</mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Weiler</surname><given-names>S</given-names></name>， <name name-style="eastern"><surname>Guggiana Nilo</surname><given-names>D</given-names></name>， <name name-style="eastern"><surname>Bonhoeffer</surname><given-names>T</given-names></name>， <etal>et al</etal></person-group>. <article-title>Orientation and direction tuning align with dendritic morphology and spatial connectivity in mouse visual cortex</article-title>［J］. <source>Curr Biol</source>， <year>2022</year>， <volume>32</volume>（<issue>8</issue>）： <fpage>1743</fpage>-<lpage>53.e7</lpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.cub.2022.02.048">10.1016/j.cub.2022.02.048</ext-link></comment>.</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Onorato</surname><given-names>I</given-names></name>， <name name-style="eastern"><surname>Tzanou</surname><given-names>A</given-names></name>， <name name-style="eastern"><surname>Schneider</surname><given-names>M</given-names></name>， <etal>et al</etal></person-group>. <article-title>Distinct roles of PV and Sst interneurons in visually induced gamma oscillations</article-title>［J］. <source>Cell Rep</source>， <year>2025</year>， <volume>44</volume>（<issue>3</issue>）： <fpage>115385</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.celrep.2025.115385">10.1016/j.celrep.2025.115385</ext-link></comment>.</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Harris</surname><given-names>A C</given-names></name>， <name name-style="eastern"><surname>Jin</surname><given-names>X T</given-names></name>， <name name-style="eastern"><surname>Greer</surname><given-names>J E</given-names></name>， <etal>et al</etal></person-group>. <article-title>Somatostatin interneurons exhibit enhanced functional output and resilience to axotomy after mild traumatic brain injury</article-title>［J］. <source>Neurobiol Dis</source>， <year>2022</year>， <volume>171</volume>： <fpage>105801</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.nbd.2022.105801">10.1016/j.nbd.2022.105801</ext-link></comment>.</mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal" publication-format="print" xml:lang="en"><person-group><name name-style="eastern"><surname>Kim</surname><given-names>O Y</given-names></name>， <name name-style="eastern"><surname>Song</surname><given-names>J</given-names></name></person-group>. <article-title>The importance of BDNF and RAGE in diabetes-induced dementia</article-title>［J］. <source>Pharmacol Res</source>， <year>2020</year>， <volume>160</volume>： <fpage>105083</fpage>. <comment>doi：<ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1016/j.phrs.2020.105083">10.1016/j.phrs.2020.105083</ext-link></comment>.</mixed-citation></ref></ref-list><fn-group><fn fn-type="other" specific-use="citation-format"><p>陈含露, 汤浩琼, 封利霞. 糖尿病早期小鼠初级视皮层受损与功能异常情况[J]. 安徽医科大学学报, 2026, 61(05): 872-879.</p></fn><fn fn-type="other" specific-use="citation-format" xml:lang="en"><p>Chen Hanlu, Tang Haoqiong, Feng Lixia. Early-stage diabetes induces structural damage and functional deficits in the mouse primary visual cortex[J]. Acta Universitatis Medicinalis Anhui, 2026, 61(05): 872-879.</p></fn></fn-group></back></article>